Dissemin is shutting down on January 1st, 2025

Published in

Springer, BioDrugs, 2(34), p. 159-170, 2019

DOI: 10.1007/s40259-019-00395-w

Links

Tools

Export citation

Search in Google Scholar

Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!

Journal article published in 2019 by Binita Dutta, Isabelle Huys, Arnold G. Vulto ORCID, Steven Simoens ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO